Parkinson’s disease symptoms “improved” by oestrogen
New research into sex-based differences of Parkinson's disease could lead to new treatments.
List view / Grid view
New research into sex-based differences of Parkinson's disease could lead to new treatments.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
A new mouse model, called 'wildlings', has been developed which better mirrors human immune responses than standard laboratory mice.
Scientists report how editing a portion of stem cells with CRISPR-Cas9 is sufficient for long-term reactivation of therapeutic haemoglobin.
New study sheds light on how the TP53 gene becomes mutated and how those mutations can help predict clinical outlooks for cancer.
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
Researchers have identified a key process behind senescence, or why cells age, which could be used to improve treatments for cancer.
Researchers have extended the life of heart segments from 24 hours to six days, enabling pre-clinical trials to experiment on these new models for longer periods of time.
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
Using human data, a new study has examined how Cryptococcus genes impact patients with Cryptococcus Neoformans.
A study has used new synthetic lipids to deliver CRISPR gene editing tools into cells with up to 90 percent efficiency.
The so-called 'longevity gene' has been included in animal models, in which it stopped atherosclerosis.
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.